These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 30173899)

  • 21. Primary membranous nephropathy in two siblings with one combined with anti-glomerular basement membrane disease: a case report.
    Cheng YJ; Jia XY; Cao HR; Zhao XY; Zhou XJ; Yu XJ; Xu R; Zhou FD; Wang SX; Cui Z; Zhao MH
    BMC Nephrol; 2023 Jun; 24(1):183. PubMed ID: 37349681
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiphospholipase A2 Receptor Antibody Levels Predict the Risk of Posttransplantation Recurrence of Membranous Nephropathy.
    Quintana LF; Blasco M; Seras M; Pérez NS; López-Hoyos M; Villarroel P; Rodrigo E; Viñas O; Ercilla G; Diekmann F; Gómez-Roman JJ; Fernandez-Fresnedo G; Oppenheimer F; Arias M; Campistol JM
    Transplantation; 2015 Aug; 99(8):1709-14. PubMed ID: 25675198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HLA-D and PLA2R1 risk alleles associate with recurrent primary membranous nephropathy in kidney transplant recipients.
    Berchtold L; Letouzé E; Alexander MP; Canaud G; Logt AV; Hamilton P; Mousson C; Vuiblet V; Moyer AM; Guibert S; Mrázová P; Levi C; Dubois V; Cruzado JM; Torres A; Gandhi MJ; Yousfi N; Tesar V; OndrejViklický ; Hourmant M; Moulin B; Rieu P; Choukroun G; Legendre C; Wetzels J; Brenchley P; Ballarín Castan JA; Debiec H; Ronco P
    Kidney Int; 2021 Mar; 99(3):671-685. PubMed ID: 32889013
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinicopathological Characteristics and Outcomes of PLA
    Luo J; Yuan Y; Tian J; Zhou Z; Su C; Yang F; Wang G
    Am J Kidney Dis; 2022 Sep; 80(3):364-372. PubMed ID: 35288217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical usefulness of autoantibodies to M-type phospholipase A2 receptor (PLA2R) for monitoring disease activity in idiopathic membranous nephropathy (IMN).
    Radice A; Trezzi B; Maggiore U; Pregnolato F; Stellato T; Napodano P; Rolla D; Pesce G; D'Amico M; Santoro D; Londrino F; Ravera F; Ortisi G; Sinico RA
    Autoimmun Rev; 2016 Feb; 15(2):146-54. PubMed ID: 26527329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating antibodies to α-enolase and phospholipase A
    Kimura Y; Miura N; Debiec H; Morita H; Yamada H; Banno S; Ronco P; Imai H
    Clin Exp Nephrol; 2017 Feb; 21(1):117-126. PubMed ID: 26830547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Diagnostic value of renal phospholipase A2 receptor and serum anti-phospholipase A2 receptor antibody in membranous nephropathy].
    Wu X; Wen S; Zhu X; Yuan S; Xu X; Yang D; Sun L; Liu H; Liu F
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Apr; 42(4):395-399. PubMed ID: 28490696
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction between PLA2R1 and HLA-DQA1 variants contributes to the increased genetic susceptibility to membranous nephropathy in Western China.
    Wang W; Fan S; Li G; Wang AY; Hong D; Zhong X; Wang L
    Nephrology (Carlton); 2019 Sep; 24(9):919-925. PubMed ID: 30467913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence, diagnostic value and clinical characteristics associated with the presence of circulating levels and renal deposits of antibodies against the M-type phospholipase A2 receptor in idiopathic membranous nephropathy.
    Segarra-Medrano A; Jatem-Escalante E; Quiles-Pérez MT; Salcedo MT; Arbós-Via MA; Ostos H; Valtierra N; Carnicer-Cáceres C; Agraz-Pamplona I
    Nefrologia; 2014 May; 34(3):353-9. PubMed ID: 24798555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunology of membranous nephropathy: from animal models to humans.
    Sinico RA; Mezzina N; Trezzi B; Ghiggeri GM; Radice A
    Clin Exp Immunol; 2016 Feb; 183(2):157-65. PubMed ID: 26459770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinicopathological features of idiopathic membranous nephropathy combined with IgA nephropathy: a retrospective analysis of 9 cases.
    Hu R; Xing G; Wu H; Zhang Z
    Diagn Pathol; 2016 Sep; 11(1):86. PubMed ID: 27624606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy.
    Stanescu HC; Arcos-Burgos M; Medlar A; Bockenhauer D; Kottgen A; Dragomirescu L; Voinescu C; Patel N; Pearce K; Hubank M; Stephens HA; Laundy V; Padmanabhan S; Zawadzka A; Hofstra JM; Coenen MJ; den Heijer M; Kiemeney LA; Bacq-Daian D; Stengel B; Powis SH; Brenchley P; Feehally J; Rees AJ; Debiec H; Wetzels JF; Ronco P; Mathieson PW; Kleta R
    N Engl J Med; 2011 Feb; 364(7):616-26. PubMed ID: 21323541
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The co-occurrence of sarcoidosis and anti-PLA2R-associated membranous nephropathy in a patient with underlying genetic susceptibility.
    Ding Y; Yao Y; Wan L; Qu Z; Yu F
    BMC Nephrol; 2024 Jun; 25(1):212. PubMed ID: 38937663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PLA2R antibody, PLA2R rs4664308 polymorphism and PLA2R mRNA levels in Tunisian patients with primary membranous nephritis.
    Dhaouadi T; Abdellatif J; Trabelsi R; Gaied H; Chamkhi S; Sfar I; Goucha R; Ben Hamida F; Ben Abdallah T; Gorgi Y
    PLoS One; 2020; 15(10):e0240025. PubMed ID: 33002091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ultrasensitive Quantitation of Anti-Phospholipase A2 Receptor Antibody as A Diagnostic and Prognostic Indicator of Idiopathic Membranous Nephropathy.
    Zhang Q; Huang B; Liu X; Liu B; Zhang Y; Zhang Z; Hua J; Fan Y; Hu L; Meng M; Wu M; Wang L; Hu Z; Sun Z
    Sci Rep; 2017 Sep; 7(1):12049. PubMed ID: 28935926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pre-transplant phospholipase A2 receptor autoantibody concentration is associated with clinically significant recurrence of membranous nephropathy post-kidney transplantation.
    Gupta G; Fattah H; Ayalon R; Kidd J; Gehr T; Quintana LF; Kimball P; Sadruddin S; Massey HD; Kumar D; King AL; Beck LH
    Clin Transplant; 2016 Apr; 30(4):461-9. PubMed ID: 26854647
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mapping the T cell epitopes of the M-type transmembrane phospholipase A2 receptor in primary membranous nephropathy.
    Zhang XD; Lin CX; Cui Z; Gu QH; Yan BJ; Liu L; Song WC; Shi Y; Debiec H; Ronco P; Zhao MH
    Kidney Int; 2023 Mar; 103(3):580-592. PubMed ID: 36549363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy.
    Debiec H; Ronco P
    N Engl J Med; 2011 Feb; 364(7):689-90. PubMed ID: 21323563
    [No Abstract]   [Full Text] [Related]  

  • 39. Anti-PLA2R Antibodies as a Prognostic Factor in PLA2R-Related Membranous Nephropathy.
    Timmermans SA; Abdul Hamid MA; Cohen Tervaert JW; Damoiseaux JG; van Paassen P;
    Am J Nephrol; 2015; 42(1):70-7. PubMed ID: 26344651
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular Pathogenesis of Membranous Nephropathy.
    Ronco P; Debiec H
    Annu Rev Pathol; 2020 Jan; 15():287-313. PubMed ID: 31622560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.